Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 24, 2011
Patent Application Number
12053382
Date Filed
March 21, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
